Getnet Yimer
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 20
- HIV/AIDS drug development and treatment 7
- Pharmacology 16
- Drug-Induced Hepatotoxicity and Protection 13
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Eyasu Makonnen (31 shared papers)Eleni Aklillu (29 shared papers)Abiy Habtewold (21 shared papers)Getachew Aderaye (18 shared papers)Wondwossen Amogne (21 shared papers)Jürgen Burhenne (12 shared papers)Lars Lindquist (10 shared papers)Leif Bertilsson (6 shared papers)
- Journals
- PLoS ONE (7 papers)BMC Infectious Diseases (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Public Health (3 papers)Toxicology Letters (3 papers)
- Partner nations
- EthiopiaUnited StatesSweden
In The Last Decade
Getnet Yimer
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 418
- Infectious Diseases 528
- Virology 120
- Hepatology 96
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Getnet Yimer
This map shows the geographic impact of Getnet Yimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Getnet Yimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Getnet Yimer more than expected).
Fields of papers citing papers by Getnet Yimer
This network shows the impact of papers produced by Getnet Yimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Getnet Yimer. The network helps show where Getnet Yimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Getnet Yimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 110 | |
| 2 | 2013 | 102 | |
| 3 | 2011 | 101 | |
| 4 | 2011 | 97 | |
| 5 | 2008 | 61 | |
| 6 | 2011 | 55 | |
| 7 | 2014 | 48 | |
| 8 | 2020 | 45 | |
| 9 | 2012 | 41 | |
| 10 | 2016 | 39 | |
| 11 | 2020 | 36 | |
| 12 | 2012 | 32 | |
| 13 | 2019 | 31 | |
| 14 | 2019 | 29 | |
| 15 | 2017 | 29 | |
| 16 | 2021 | 27 | |
| 17 | 2016 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2015 | 23 |
About Getnet Yimer
Getnet Yimer is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Public Health, Environmental and Occupational Health and Oncology, having authored 86 papers that have together received 1.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (20 papers), Drug-Induced Hepatotoxicity and Protection (13 papers), HIV/AIDS drug development and treatment (7 papers), Zoonotic diseases and public health (5 papers), HIV-related health complications and treatments (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Child Nutrition and Water Access (3 papers). The work is most often cited by research in Pharmacology (418 citations), Infectious Diseases (528 citations), Virology (120 citations), Hepatology (96 citations) and Applied Microbiology and Biotechnology (16 citations). Getnet Yimer has collaborated with scholars based in Ethiopia, United States and Sweden. Frequent co-authors include Eyasu Makonnen, Eleni Aklillu, Abiy Habtewold, Getachew Aderaye, Wondwossen Amogne, Jürgen Burhenne, Lars Lindquist, Leif Bertilsson, Akira Suda and Klaus‐Dieter Riedel. Their work appears in journals such as PLoS ONE, BMC Infectious Diseases, Frontiers in Pharmacology, Frontiers in Public Health and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.